At Lipidor, Marianne Avila will strengthen the operational team and contribute to development, primarily in purchasing and logistics, which are vital functions as the company approaches commercialization. Lipidor already has a commercial agreement in place, and work is underway for additional commercial contracts, for the company's drug candidates for the treatment of psoriasis.

Marianne Avila took up the newly created position during the month of March, and reports to the Chief Development Officer, Anders Hagman. Her background and experience include areas such as purchasing, logistics, sales and regulatory issues in the pharmaceutical industry, including at FrostPharma AB, Air Liquide Gas AB, AstraZeneca and from Stockholm Regional Council, where she worked in procurement of pharmaceuticals. Marianne holds a master's degree in molecular biology from Purdue University in the United States.

"It is gratifying to welcome Marianne Avila to Lipidor. Recruitment to the new position of Supply Chain & Operations Manager is a natural step in strengthening our operational team, ahead of the company's continued development. Lipidor is now entering a new phase and we are preparing for a commercialization of our psoriasis candidates,” says Ola Holmlund, CEO of Lipidor.

Publication

The information was provided for publication by Lipidor’s CEO on 25^th March 2022 at 11.30am (CET).